Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
The GHTC released its 2012 policy report at a Capitol Hill briefing this week. The report provides recommendations for policymakers so they can continue to save lives around the world by supporting research and development for new global health products. This is the third annual report released by the GHTC.
The Infectious Disease Research Institute announced that the first clinical trial for a new vaccine for visceral leishmaniasis has begun in Washington State.
The US Food and Drug Administration has approved the first-ever 4-in-1 flu vaccine.
The Office of Science and Technology Policy has completed its review of final drafts of new federal scientific integrity policies. More than a dozen federal departments and agencies contributed to the process.
Secretary of State Hillary Rodham Clinton testified in front of the Senate Appropriations Subcommittee on State and Foreign Operations on Tuesday. She discussed the Global Health Initiative and how it’s “consolidating programs, increasing partners' capacities, and shifting responsibilities to help target our resources where they are most needed and [have the] highest impact.”